Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference
Agile Therapeutics (Nasdaq: AGRX), a women's healthcare company, announced that its CEO, Al Altomari, will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on May 19, 2021, at 1:20 p.m. ET. The event will be accessible via live webcast on the Investor Relations page of Agile Therapeutics' website and will be archived for 30 days. Agile Therapeutics focuses on contraceptive solutions, including its product Twirla, a non-daily prescription contraceptive.
- None.
- None.
PRINCETON, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 1:20 p.m. ET.
The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here: https://event.on24.com/wcc/r/3173531/F391B23E756682EFEFE4952267784F45
The webcast will be archived on the Agile Therapeutics website for 30 days following the event.
About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
FAQ
When will Agile Therapeutics' CEO participate in the RBC Capital Markets Global Healthcare Conference?
How can I access the webcast of the Agile Therapeutics fireside chat?
What is Twirla and what does it offer?
How long will the Agile Therapeutics webcast be available for viewing?
